ClinicalTrials.Veeva

Menu

The Radiation Oncology Registry and Biosample Repository

Abramson Cancer Center at Penn Medicine logo

Abramson Cancer Center at Penn Medicine

Status

Enrolling

Conditions

Neoplasia

Study type

Observational

Funder types

Other

Identifiers

NCT01577251
UPCC 11908

Details and patient eligibility

About

The goal of this study is to establish a registry and biosample repository (defined as blood, urine, and tumor specimens) in patients with a cancer and/or benign tumor diagnosis undergoing radiotherapy.

Enrollment

8,000 estimated patients

Sex

All

Ages

18 to 89 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy
  • Able to sign consent

Trial contacts and locations

4

Loading...

Central trial contact

Project Manager

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems